These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Tissue-specific expression and regulation of GSK-3 in human skeletal muscle and adipose tissue. Ciaraldi TP; Oh DK; Christiansen L; Nikoulina SE; Kong AP; Baxi S; Mudaliar S; Henry RR Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E891-8. PubMed ID: 16757548 [TBL] [Abstract][Full Text] [Related]
43. Phosphorus Overload Promotes Hepatic Lipolysis by Suppressing GSK3β-Dependent Phosphorylation of PPARα at Ser84 and Thr265 in a Freshwater Teleost. Xu YC; Pantopoulos K; Zheng H; Zito E; Zhao T; Tan XY; Wei XL; Song YF; Luo Z Environ Sci Technol; 2023 Feb; 57(6):2351-2361. PubMed ID: 36728683 [TBL] [Abstract][Full Text] [Related]
44. Chemical composition and pharmacological properties of Macaranga-type Pacific propolis: A review. Shahinozzaman M; Obanda DN; Tawata S Phytother Res; 2021 Jan; 35(1):207-222. PubMed ID: 32776610 [TBL] [Abstract][Full Text] [Related]
45. A Systematic Review of the Potential Effects of Propolis Extracts on Experimentally-induced Diabetes. Cunha GAD; Carlstrom PF; Franchin M; Alencar SM; Ikegaki M; Rosalen PL Planta Med; 2023 Mar; 89(3):236-244. PubMed ID: 36170859 [TBL] [Abstract][Full Text] [Related]
46. Biomedical Properties of Propolis on Diverse Chronic Diseases and Its Potential Applications and Health Benefits. Rivera-Yañez N; Rivera-Yañez CR; Pozo-Molina G; Méndez-Catalá CF; Méndez-Cruz AR; Nieto-Yañez O Nutrients; 2020 Dec; 13(1):. PubMed ID: 33383693 [TBL] [Abstract][Full Text] [Related]
47. The action of antidiabetic plants of the canadian james bay cree traditional pharmacopeia on key enzymes of hepatic glucose homeostasis. Nachar A; Vallerand D; Musallam L; Lavoie L; Badawi A; Arnason J; Haddad PS Evid Based Complement Alternat Med; 2013; 2013():189819. PubMed ID: 23864882 [TBL] [Abstract][Full Text] [Related]
48. Potential Role of Propolis in the Prevention and Treatment of Metabolic Diseases. Balica G; Vostinaru O; Stefanescu C; Mogosan C; Iaru I; Cristina A; Pop CE Plants (Basel); 2021 Apr; 10(5):. PubMed ID: 33925692 [TBL] [Abstract][Full Text] [Related]
49. Propolis and its direct and indirect hypoglycemic effect. Al-Hariri MT J Family Community Med; 2011 Sep; 18(3):152-4. PubMed ID: 22175043 [TBL] [Abstract][Full Text] [Related]
50. Propolis in Metabolic Syndrome and Its Associated Chronic Diseases: A Narrative Review. Zulhendri F; Ravalia M; Kripal K; Chandrasekaran K; Fearnley J; Perera CO Antioxidants (Basel); 2021 Feb; 10(3):. PubMed ID: 33652692 [TBL] [Abstract][Full Text] [Related]
51. Evidence on the Health Benefits of Supplemental Propolis. Braakhuis A Nutrients; 2019 Nov; 11(11):. PubMed ID: 31717277 [TBL] [Abstract][Full Text] [Related]
53. The effects of MIND diet and propolis supplementation on metabolic syndrome: A randomized controlled clinical trial. Gholami Z; Maracy MR; Paknahad Z Heliyon; 2024 Aug; 10(16):e34493. PubMed ID: 39220895 [TBL] [Abstract][Full Text] [Related]
54. Effects of MIND diet and propolis supplementation on metabolic syndrome indices and cognitive function among patients with metabolic syndrome in Isfahan, Iran, 2024. A rationale and study protocol for randomized controlled trial. Gholami Z; Maracy MR; Paknahad Z Health Sci Rep; 2024 Aug; 7(8):e2262. PubMed ID: 39135701 [TBL] [Abstract][Full Text] [Related]
56. Effects of Iranian propolis on renal function, prooxidant-antioxidant balance, metabolic status, and quality of life in patients with chronic kidney disease: A study protocol of an ongoing randomized, double-blind, placebo-controlled clinical trial. Anvarifard P; Anbari M; Ostadrahimi A; Ardalan M; Ghoreishi Z Contemp Clin Trials Commun; 2023 Aug; 34():101159. PubMed ID: 37360969 [TBL] [Abstract][Full Text] [Related]
57. Propolis: An update on its chemistry and pharmacological applications. Hossain R; Quispe C; Khan RA; Saikat ASM; Ray P; Ongalbek D; Yeskaliyeva B; Jain D; Smeriglio A; Trombetta D; Kiani R; Kobarfard F; Mojgani N; Saffarian P; Ayatollahi SA; Sarkar C; Islam MT; Keriman D; Uçar A; Martorell M; Sureda A; Pintus G; Butnariu M; Sharifi-Rad J; Cho WC Chin Med; 2022 Aug; 17(1):100. PubMed ID: 36028892 [TBL] [Abstract][Full Text] [Related]
58. A comprehensive insight into the molecular and cellular mechanisms of the effects of Propolis on preserving renal function: a systematic review. Anvarifard P; Anbari M; Ostadrahimi A; Ardalan M; Ghoreishi Z Nutr Metab (Lond); 2022 Jan; 19(1):6. PubMed ID: 35057819 [TBL] [Abstract][Full Text] [Related]
59. A propolis-derived small molecule ameliorates metabolic syndrome in obese mice by targeting the CREB/CRTC2 transcriptional complex. Chen Y; Wang J; Wang Y; Wang P; Zhou Z; Wu R; Xu Q; You H; Liu Y; Wang L; Zhou L; Wu Y; Hu L; Liu H; Liu Y Nat Commun; 2022 Jan; 13(1):246. PubMed ID: 35017472 [TBL] [Abstract][Full Text] [Related]
60. Effects of propolis supplementation on glycemic status, lipid profiles, inflammation and oxidative stress, liver enzymes, and body weight: a systematic review and meta-analysis of randomized controlled clinical trials. Hallajzadeh J; Milajerdi A; Amirani E; Attari VE; Maghsoudi H; Mirhashemi SM J Diabetes Metab Disord; 2021 Jun; 20(1):831-843. PubMed ID: 34178866 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]